11-5249459-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong
The NM_000559.3(HBG1):c.224C>A(p.Ala75Asp) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000559.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary persistence of fetal hemoglobin-beta-thalassemia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- delta-beta-thalassemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-sickle cell disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000258 AC: 2AN: 77574Hom.: 1 Cov.: 10 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 789084Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 399362
GnomAD4 genome AF: 0.0000258 AC: 2AN: 77574Hom.: 1 Cov.: 10 AF XY: 0.00 AC XY: 0AN XY: 37490 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.224C>A (p.A75D) alteration is located in exon 2 (coding exon 2) of the HBG1 gene. This alteration results from a C to A substitution at nucleotide position 224, causing the alanine (A) at amino acid position 75 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at